Cincoze Launches 15.6″ FHD Panel PC and Monitor for Industrial and Outdoor Applications
TAIPEI, Taiwan–(BUSINESS WIRE)–#IndustrialHMI–Rugged embedded computer brand—Cincoze has added a new 15.6-inch FHD display option for HMI applications... Read more.
Relo Metrics Expands Census Product into Formula One and Advances Sponsorship Valuation for the Global Motorsports Industry
Using Computer-Vision Powered Scene Detection, Relo Adds Sponsorship Valuation of all F1 Races, Teams, Brands as Sponsorship Spend Looks to Reach $2.9 Billion Revenue... Read more.
Revitalize Your Space: Essential Spring Cleaning Tips for a Healthier Home
Unlock a Smarter, Healthier Home with Tineco’s Advanced Cleaning Tools SEATTLE–(BUSINESS WIRE)–As spring ushers in longer days and fresh air, it presents... Read more.
AlbaCore Launches its Senior Direct Lending Strategy, with Commitments from ADIA and Mitsubishi UFJ Trust and Banking Corporation
LONDON–(BUSINESS WIRE)–European credit specialist AlbaCore Capital Group (“AlbaCore”) today announces the launch of a new Senior Direct Lending Strategy... Read more.
MaaT Pharma Completes a Capital Increase of €13 Million with Historical Shareholders and Announces 2024 Annual Results
Positive results from Phase 3 trial for MaaT013 in acute Graft-versus-Host disease (aGvHD); topline results (January 2025) showed a 62% gastrointestinal overall... Read more.
Curatis: Sales growth of 30% in distribution – plus significant expansion of patient target group for lead project C-PTBE-01
LIESTAL, Switzerland–(BUSINESS WIRE)–Curatis Holding AG (SIX:CURN, ‘Curatis’) reports business revenues of CHF 6.9m for 2024, whereby Curatis AG... Read more.
Nederlandse Innovatie Maatschappij (NIM) Leads H2ESTIA Project: The Future of Emission-Free Cargo Transport
SLIEDRECHT, Netherlands–(BUSINESS WIRE)–The maritime industry is taking a large step toward sustainability with the launch of the H2ESTIA Project, a... Read more.
Innate Pharma Reports Full Year 2024 Financial Results and Business Update
FDA Breakthrough Therapy Designation granted to lacutamab for relapsed or refractory Sézary syndrome New data, including lacutamab improved health-related quality... Read more.
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis
Health Canada’s approval enables 4Moving Biotech to initiate the INFLAM MOTION Phase 2a clinical trial The INFLAM MOTION trial serves as a proof-of-concept study... Read more.
James Gorman Joins General Atlantic as Senior Advisor
NEW YORK–(BUSINESS WIRE)–General Atlantic, a leading global investor, today announced that James Gorman will join the firm as a Senior Advisor, effective... Read more.